Cyclacel Pharmaceuticals, Inc.
CYCC
$7.99
-$0.01-0.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.75% | 23.30% | -7.13% | -49.83% | -40.97% |
| Total Receivables | -- | -- | -- | -50.61% | -50.13% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -88.45% | -78.72% | -70.08% | -45.95% | -56.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -80.67% | -46.85% | -12.02% | -84.15% | -86.28% |
| Total Current Assets | -43.13% | -23.19% | -50.64% | -55.79% | -49.61% |
|
|
|||||
| Total Current Assets | -43.13% | -23.19% | -50.64% | -55.79% | -49.61% |
| Net Property, Plant & Equipment | -74.29% | -76.74% | -92.16% | -56.00% | -52.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -67.28% | -67.20% | -58.70% |
| Total Assets | -46.26% | -39.43% | -53.50% | -56.94% | -50.19% |
|
|
|||||
| Total Accounts Payable | -95.34% | -97.81% | 29.81% | 162.64% | 118.58% |
| Total Accrued Expenses | -75.56% | -81.36% | -67.30% | -69.57% | -52.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -90.38% | -94.26% | -25.53% | -6.74% | 68.80% |
| Total Other Current Liabilities | -90.38% | -94.26% | -25.53% | -6.74% | 68.80% |
| Total Current Liabilities | -89.42% | -92.06% | -23.20% | -22.05% | 6.52% |
|
|
|||||
| Total Current Liabilities | -89.42% | -92.06% | -23.20% | -22.05% | 6.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 100.00% | -57.14% | -- | -- | -92.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -89.29% | -91.97% | -23.54% | -22.55% | -36.40% |
|
|
|||||
| Common Stock & APIC | 2.06% | 3.16% | 1.96% | 1.87% | 3.01% |
| Retained Earnings | -1.68% | -2.14% | -2.62% | -3.18% | -4.09% |
| Treasury Stock & Other | -- | 100.11% | 1.87% | 11.56% | 16.59% |
| Total Common Equity | 263.16% | 238.80% | -458.15% | -122.57% | -80.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 263.16% | 238.80% | -458.15% | -122.57% | -80.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 263.46% | 238.80% | -458.15% | -122.57% | -80.55% |
|
|
|||||